Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov 17;16(22):6737-47.
doi: 10.1093/emboj/16.22.6737.

Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor

Affiliations

Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor

U Gether et al. EMBO J. .

Abstract

Agonist binding to G protein-coupled receptors is believed to promote a conformational change that leads to the formation of the active receptor state. However, the character of this conformational change which provides the important link between agonist binding and G protein coupling is not known. Here we report evidence that agonist binding to the beta2 adrenoceptor induces a conformational change around 125Cys in transmembrane domain (TM) III and around 285Cys in TM VI. A series of mutant beta2 adrenoceptors with a limited number of cysteines available for chemical derivatization were purified, site-selectively labeled with the conformationally sensitive, cysteine-reactive fluorophore IANBD and analyzed by fluorescence spectroscopy. Like the wild-type receptor, mutant receptors containing 125Cys and/or 285Cys showed an agonist-induced decrease in fluorescence, while no agonist-induced response was observed in a receptor where these two cysteines were mutated. These data suggest that IANBD bound to 125Cys and 285Cys are exposed to a more polar environment upon agonist binding, and indicate that movements of transmembrane segments III and VI are involved in activation of G protein-coupled receptors.

PubMed Disclaimer

References

    1. J Biol Chem. 1995 Aug 18;270(33):19532-9 - PubMed
    1. Protein Eng. 1994 Dec;7(12):1441-8 - PubMed
    1. J Med Chem. 1992 Sep 18;35(19):3448-62 - PubMed
    1. Annu Rev Neurosci. 1992;15:87-114 - PubMed
    1. J Recept Res. 1994 May;14(3-4):167-86 - PubMed

Publication types

MeSH terms